Molecular pathogenesis of secondary hyperparathyroidism in renal failure: basic and clinical aspects.
Fukagawa
M
M
First Department of Internal Medicine, University of Tokyo School of Medicine, Tokyo Teishin Hospital, Japan.
Iwasaki
Y
Y
D002117:Calcitriol / Q000627:therapeutic use; D002120:Calcium Channel Agonists / Q000627:therapeutic use; D004351:Drug Resistance / Q000502:physiology; D018014:Gene Transfer Techniques; D006801:Humans; D006961:Hyperparathyroidism / Q000209:etiology* / Q000628:therapy; D007676:Kidney Failure, Chronic / Q000150:complications*; D010280:Parathyroid Glands / Q000473:pathology; D014511:Uremia / Q000188:drug therapy
D002120:Calcium Channel Agonists; D002117:Calcitriol